China – Medxy AI

Cancer Statistics in China: Current Landscape, Risk Factors, and Preventive Strategies

By MedXY 01/14/2026

This article reviews the epidemiological transition of cancer in China, highlighting incidence, mortality, survival trends, major modifiable risk factors, and national prevention and control efforts.

Diabetes & Endocrinology news

Efficacy and Safety of Tirzepatide Added to Basal Insulin in Chinese Patients with Type 2 Diabetes: Insights from the SURPASS-CN-INS Phase 3 Trial

By MedXY 11/17/2025

This phase 3 study demonstrates that adding tirzepatide to basal insulin significantly improves glycemic control in Chinese patients with type 2 diabetes, with a manageable safety profile.

news Ophthalmology

Cenegermin Eye Drops Show High Healing Rates in Chinese Patients with Moderate–Severe Neurotrophic Keratopathy

By MedXY 11/02/2025

A prospective phase IV open‑label Chinese study found cenegermin achieved corneal healing in 84.6% of stage 2/3 neurotrophic keratopathy patients at 8 weeks, with durable effects through 56 weeks and an acceptable safety profile.